Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ascendis Pharma A/S (ASND) vs Vistra Corp (VST) Price & Performance

Ascendis Pharma A/STrade
Vistra CorpTrade

Price performance (Past 24H)

Key statistics

Ascendis Pharma A/S vs Vistra Corp — how do they compare? Ascendis Pharma A/S trades at $255.5 (market cap $16.67B), while Vistra Corp trades at $148.69 (market cap $48.64B). The key difference: Vistra Corp is far larger — about 2.9× Ascendis Pharma A/S's market cap, and Vistra Corp pays a 0.63% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.

ASNDVST
Market Cap
$16.67B$48.64B
Sector
HealthTechnology
52-Week High
$277.18$217.92
52-Week Low
$189.74$134.71
Enterprise Value
$17.04B$70.58B
Dividend Yield
0.63%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Ascendis Pharma A/S

Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.

Read more on ASND

About Vistra Corp

Vistra is a leading integrated retail electricity and power generation company that serves as a critical infrastructure provider for the digital economy. It operates a diversified portfolio of zero-carbon nuclear and renewable assets alongside a massive, flexible natural gas fleet, positioning it as an indispensable partner for energy-intensive AI data centers and industrial electrification.

Read more on VST